Dipeptidyl peptidase-4 inhibitor linagliptin attenuates neointima formation after vascular injury
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1475-2840
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Dipeptidyl peptidase-4 inhibitor linagliptin attenuates neointima formation after vascular injury ; volume:13 ; number:1 ; day:19 ; month:11 ; year:2014 ; pages:1-8 ; date:12.2014
Cardiovascular diabetology ; 13, Heft 1 (19.11.2014), 1-8, 12.2014
- Creator
-
Terawaki, Yuichi
Nomiyama, Takashi
Kawanami, Takako
Hamaguchi, Yuriko
Takahashi, Hiroyuki
Tanaka, Tomoko
Murase, Kunitaka
Nagaishi, Ryoko
Tanabe, Makito
Yanase, Toshihiko
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/s12933-014-0154-3
- URN
-
urn:nbn:de:101:1-2021082219245036882252
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:50 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Terawaki, Yuichi
- Nomiyama, Takashi
- Kawanami, Takako
- Hamaguchi, Yuriko
- Takahashi, Hiroyuki
- Tanaka, Tomoko
- Murase, Kunitaka
- Nagaishi, Ryoko
- Tanabe, Makito
- Yanase, Toshihiko
- SpringerLink (Online service)
Other Objects (12)
Dipeptidyl peptidase-4 inhibition with linagliptin prevents western diet-induced vascular abnormalities in female mice
Efficacy of dipeptidyl peptidase-4 inhibitor linagliptin in patients with type 2 diabetes undergoing hemodialysis
Dipeptidyl peptidase IV inhibitor attenuates kidney injury in rat remnant kidney
Renal effects of the dipeptidyl peptidase inhibitor linagliptin in non-diabetic rats with 5/6 nephrectomy
Evogliptin, a dipeptidyl peptidase-4 inhibitor, attenuates pathological retinal angiogenesis by suppressing vascular endothelial growth factor-induced Arf6 activation
Dipeptidyl peptidase IV : general and applied aspects
Dipeptidyl-Peptidase IV : Biochemie, Physiologie u. Pathobiochemie
Angioedema associated with dipeptidyl peptidase-IV inhibitors
Dipeptidyl peptidase-4 (DPP-4) inhibition with linagliptin reduces western diet-induced myocardial TRAF3IP2 expression, inflammation and fibrosis in female mice
Beiträge zur kinetischen Charakterisierung der Dipeptidyl-Peptidase IV
Development of dipeptidyl peptidase 8 and 9 inhibitors
Population pharmacokinetic and pharmacodynamic modelling and simulation of linagliptin, a novel dipeptidyl-peptidase 4 inhibitor for the treatment of type 2 diabetes
Dipeptidyl peptidase-4 inhibition with linagliptin prevents western diet-induced vascular abnormalities in female mice
Efficacy of dipeptidyl peptidase-4 inhibitor linagliptin in patients with type 2 diabetes undergoing hemodialysis
Dipeptidyl peptidase IV inhibitor attenuates kidney injury in rat remnant kidney
Renal effects of the dipeptidyl peptidase inhibitor linagliptin in non-diabetic rats with 5/6 nephrectomy
Evogliptin, a dipeptidyl peptidase-4 inhibitor, attenuates pathological retinal angiogenesis by suppressing vascular endothelial growth factor-induced Arf6 activation
Dipeptidyl peptidase IV : general and applied aspects
Dipeptidyl-Peptidase IV : Biochemie, Physiologie u. Pathobiochemie
Angioedema associated with dipeptidyl peptidase-IV inhibitors
Dipeptidyl peptidase-4 (DPP-4) inhibition with linagliptin reduces western diet-induced myocardial TRAF3IP2 expression, inflammation and fibrosis in female mice
Beiträge zur kinetischen Charakterisierung der Dipeptidyl-Peptidase IV
Development of dipeptidyl peptidase 8 and 9 inhibitors
Population pharmacokinetic and pharmacodynamic modelling and simulation of linagliptin, a novel dipeptidyl-peptidase 4 inhibitor for the treatment of type 2 diabetes
Dipeptidyl peptidase-4 inhibition with linagliptin prevents western diet-induced vascular abnormalities in female mice
Efficacy of dipeptidyl peptidase-4 inhibitor linagliptin in patients with type 2 diabetes undergoing hemodialysis
Dipeptidyl peptidase IV inhibitor attenuates kidney injury in rat remnant kidney
Renal effects of the dipeptidyl peptidase inhibitor linagliptin in non-diabetic rats with 5/6 nephrectomy
Evogliptin, a dipeptidyl peptidase-4 inhibitor, attenuates pathological retinal angiogenesis by suppressing vascular endothelial growth factor-induced Arf6 activation
Dipeptidyl peptidase IV : general and applied aspects
Dipeptidyl-Peptidase IV : Biochemie, Physiologie u. Pathobiochemie
Angioedema associated with dipeptidyl peptidase-IV inhibitors
Dipeptidyl peptidase-4 (DPP-4) inhibition with linagliptin reduces western diet-induced myocardial TRAF3IP2 expression, inflammation and fibrosis in female mice
Beiträge zur kinetischen Charakterisierung der Dipeptidyl-Peptidase IV
Development of dipeptidyl peptidase 8 and 9 inhibitors